当前位置: 首页» 科研进展» 最新论文

最新论文

Rv3091, An Extracellular Patatin-Like Phospholipase in Mycobacterium tuberculosis, Prolongs Intracellular Survival of Recombinant Mycolicibacterium smegmatis by Mediating Phagosomal Escape.Front Microbiol.2020 Sep 11;11:2204.doi: 10.3389/fmicb.2020.532371. eCollection 2020

Ziyin Cui , Guanghui Dang , Ningning Song , Yingying Cui , Zhe Li , Xinxin Zang , Hongxiu Liu , Zhongxing Wang , Siguo Liu 

 

Front Microbiol.2020 Sep 11;11:2204.doi: 10.3389/fmicb.2020.532371. eCollection 2020.

 

Abstract

Patatin-like phospholipases (PLPs) are important virulence factors of many pathogens. However, there are no prevailing studies regarding PLPs as a virulence factor of Mycobacterium tuberculosis (Mtb). Analysis of Rv3091, a putative protein of Mtb, shows that it belongs to the PLPs family. Here, we cloned and expressed the rv3091 gene in Mycobacterium smegmatis and, subsequently, conducted protein purification and characterization. We show that it possesses phospholipase A1, phospholipase A2, and lipase activity. We confirm the putative active site residues, namely, Ser214 and Asp407, using site directed mutagenesis. The Rv3091 is an extracellular protein that alters the colony morphology of M. smegmatis. The presence of Rv3091 enhances the intracellular survival capability of M. smegmatis in murine peritoneal macrophages. Additionally, it promotes M. smegmatis phagosomal escape from macrophages. Moreover, Rv3091 significantly increased the survival of M. smegmatis and aggravated lesions in C57BL/6 J murine lungs in vivo. Taken together, our results indicate that Rv3091 as an extracellular PLP that is critical to the pathogenicity of mycobacterium as it allows mycobacterium to utilize phospholipids for its growth and provides resistance to phagosome killing, resulting in its enhanced intracellular survival.

Keywords: Mycobacterium tuberculosis; intracellular survival; lipase; patatin-like phospholipase; phagosome escape.

Copyright © 2020 Cui, Dang, Song, Cui, Li, Zang, Liu, Wang and Liu.

扫一扫 关注我
网站首页 联系我们
TOP